Athersys Inc. (Nasdaq: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (MSB: ASX), Osiris (Nasdaq: OSIR) and ThermoGenesis Corp (Nasdaq: KOOL), recently announced that its CEO would deliver the keynote address at the World Stem Cell Summit 2011.
Recent Posts
- NIH Ends Funding for Research Using Human Fetal Tissue
- Mum hails cord blood donation after life-saving transplant
- Stem cell engineering breakthrough paves way for next-generation living drugs
- How genetically modified stem cells could repair the brain after a stroke
- How TikTok can be used to recruit young stem cell donors
- ChatGPT Health and what AI can do for a broken system
